Bone Biologics (BBLG) Payables (2016 - 2017)
Historic Payables for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $3.6 million.
- Bone Biologics' Payables rose 98096.01% to $3.6 million in Q3 2017 from the same period last year, while for Sep 2017 it was $3.6 million, marking a year-over-year increase of 98096.01%. This contributed to the annual value of $1.5 million for FY2016, which is N/A changed from last year.
- Latest data reveals that Bone Biologics reported Payables of $3.6 million as of Q3 2017, which was up 98096.01% from $2.5 million recorded in Q2 2017.
- Bone Biologics' Payables' 5-year high stood at $3.6 million during Q3 2017, with a 5-year trough of $335622.0 in Q3 2016.